Times are displayed in (UTC-05:00) Eastern Time (US & Canada) Change
| to
Getting Real About C-L Psychiatrists Treating Addiction
As of June 2020, 13% of Americans reported starting or increasing substance use as a way of coping with stress or emotions related to COVID-19. This has been accompanied by increases in overdoses and other opioid-related mortality and adds to the millions of American adults and adolescents already suffering from comorbid substance use and mental health issues pre-pandemic.
Many of these patients are seen in acute care settings such as emergency departments or hospitals, often making consultation-liaison (C-L) psychiatrists the de facto addiction specialists.
The pre-recorded portion of this workshop will cover a variety of complex addiction-related issues relevant to C-L psychiatrists:
Substance use in pregnancy: Dr. Forray, a reproductive psychiatrist with addiction training, will provide overview of perinatal substance abuse including epidemiology, impact on outcomes, fetal effects and treatment approaches in pregnancy.
Substance use disorders in end-stage medical disease: Dr. Winder, a C-L psychiatrist, will discuss approaches to substance use disorder (SUD) in end-stage medical diseases along with key challenges and opportunities as patients move toward transplant and practical aspects of the needed interprofessional approach to these efforts.
Cannabis for the C-L psychiatrist: Dr. Thant will review cannabis “basics” for medically complex patients in addition to lesser-known topics such as the role of cannabis in altered mental status (delirium, catatonia) and agitation.
Opioid use disorder in the general hospital: Dr. Sidelnik, an addiction psychiatrist, will provide an overview of opioid use disorder in the general hospital including management of withdrawal, treatment of opioid use disorder, treatment of co-occurring pain, harm and stigma reduction, patient directed discharges and the role of C-L psychiatrists in facilitating medical treatment.
Psychedelics: Dr. Suzuki, an addiction psychiatrist, will provide an overview of psychedelics and the presentations in the C-L setting of the harms associated with their use. Additional topics will include the emerging evidence base for psychedelic use in SUD treatment, associated mechanisms and potential roles in the C-L setting.
Speakers will present clinical scenarios often faced by C-L psychiatrists and work with the audience on reviewing the latest data and treatment modalities through case presentations and didactics for group discussion.
The interactive portion of this workshop will engage the audience through complex case discussions highlighting each of the above topics followed by a question-and-answer session. Facilitators will guide audience members through high-yield learning points, practical tips and updates of evolving science related to evaluation and treatment of substance use with the goal of improving participants’ knowledge base and clinical skills
References:
1. https://www.apa.org/monitor/2021/03/substance-use-pandemic
2. Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration (2018).
Many of these patients are seen in acute care settings such as emergency departments or hospitals, often making consultation-liaison (C-L) psychiatrists the de facto addiction specialists.
The pre-recorded portion of this workshop will cover a variety of complex addiction-related issues relevant to C-L psychiatrists:
Substance use in pregnancy: Dr. Forray, a reproductive psychiatrist with addiction training, will provide overview of perinatal substance abuse including epidemiology, impact on outcomes, fetal effects and treatment approaches in pregnancy.
Substance use disorders in end-stage medical disease: Dr. Winder, a C-L psychiatrist, will discuss approaches to substance use disorder (SUD) in end-stage medical diseases along with key challenges and opportunities as patients move toward transplant and practical aspects of the needed interprofessional approach to these efforts.
Cannabis for the C-L psychiatrist: Dr. Thant will review cannabis “basics” for medically complex patients in addition to lesser-known topics such as the role of cannabis in altered mental status (delirium, catatonia) and agitation.
Opioid use disorder in the general hospital: Dr. Sidelnik, an addiction psychiatrist, will provide an overview of opioid use disorder in the general hospital including management of withdrawal, treatment of opioid use disorder, treatment of co-occurring pain, harm and stigma reduction, patient directed discharges and the role of C-L psychiatrists in facilitating medical treatment.
Psychedelics: Dr. Suzuki, an addiction psychiatrist, will provide an overview of psychedelics and the presentations in the C-L setting of the harms associated with their use. Additional topics will include the emerging evidence base for psychedelic use in SUD treatment, associated mechanisms and potential roles in the C-L setting.
Speakers will present clinical scenarios often faced by C-L psychiatrists and work with the audience on reviewing the latest data and treatment modalities through case presentations and didactics for group discussion.
The interactive portion of this workshop will engage the audience through complex case discussions highlighting each of the above topics followed by a question-and-answer session. Facilitators will guide audience members through high-yield learning points, practical tips and updates of evolving science related to evaluation and treatment of substance use with the goal of improving participants’ knowledge base and clinical skills
References:
1. https://www.apa.org/monitor/2021/03/substance-use-pandemic
2. Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration (2018).
Speakers
Thida Thant
Director of the University of Colorado Consultation-Liaison Psychiatry Service | University of Colorado, Aurora
Dr. Thida Thant is an assistant professor at the University of Colorado Department of Psychiatry. She holds a medical degree from the University of Texas Medical School in Houston and graduated with a Bachelor of Arts Degree in Plan II Honors from the University of Texas in Austin. She completed her general adult psychiatry residency and psychosomatic medicine fellowship at the University of Colorado and is the Director of the University of Colorado Consultation-Liaison Psychiatry Service and the Psychiatric Consultation for the Medically Complex clinic. Her academic interests include marijuana and its impact on psychiatric practice, the creation and implementation of marijuana curricula in medical education, psychiatric care for medically and neurologically complex patients, multi-modal group approaches for patients with chronic medical illness and alternative diagnostic systems such as the NIMH Research Domain Criteria (RDoC).
Gerald Scott Winder
Clinical Associate Professor of Psychiatry, Surgery, & Neurology | University of Michigan
Dr. Gerald Scott Winder is a clinical associate professor in the Departments of Psychiatry, Surgery, and Neurology at the University of Michigan. He holds a medical degree from the University of Utah School of Medicine and a Masters of Science degree from the University of Michigan School of Public Health. He completed a general psychiatry residency and a consultation-liaison psychiatry fellowship at the University of Michigan. As a consultation-liaison psychiatrist, Dr. Winder specializes in the psychiatric care of the medically ill. In this clinical niche, he has co-founded specialty clinics embedded in organ transplantation, neurology, and hepatology working on interprofessional teams providing integrated psychiatric and medical care to patients whose diseases cross medical disciplines.
Joji Suzuki
Director, Division of Addiction Psychiatry, Brigham and Women's Hospital | Assistant Professor of Psychiatry, Harvard Medical School
Dr Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital (BWH), and an Assistant Professor of Psychiatry at Harvard Medical School (HMS). Dr Suzuki has been a consultation-liaison psychiatrist in the Division of Medical Psychiatry at BWH, and currently serves as the interim Director for the BWH Bridge Clinic as well as the Program Director for the BWH Addiction Medicine Fellowship. He has been very active in both medical student, resident and fellow education throughout his career. He is a member of Motivational Interviewing Network of Trainers and is the course director for the HMS CME course on motivational interviewing. His research has received funding from National Institute on Drug Abuse (NIDA), CDC, BWH, and HMS. In 2018 he was awarded a NIDA K23 Career Development Award to receive mentored training in conducting clinical trials, and to study the impact of recovery coaches on buprenorphine treatment outcomes. He is a sought-out speaker both locally and nationally, and currently serves on a variety of committees, workgroups, and taskforces for Mass General Brigham, BWH, HMS, and the State of Massachusetts to address the opioid epidemic.
Simon Sidelnik
Director Addiction Consultation-Liaison Psychiatry | NYU Grossman School of Medicine
Dr. Sidelnik works as the Director of Addiction Consultation-Liaison Psychiatry at NYU Langone, Tisch Hospital. He completed his Adult Psychiatry training at Massachusetts General Hospital/McLean Hospital and completed fellowships in Consultation-Liaison Psychiatry and Addiction Psychiatry at NYU School of Medicine. Dr. Sidelnik has particular interests in integrating substance use disorder treatment into medical settings, management of comorbid pain and opioid use disorder, harm reduction, and caring for people who inject drugs. He also has an interest in medical education and is part of the faculty of the NYU Consultation-Liaison Psychiatry and Addiction Psychiatry Fellowships. Dr. Sidelnik has worked to educate house staff on treating patients with substance use disorders in hospital settings and has given several Grand Rounds on the topic. He serves on several hospital committees including Substance Use Disorder Committee and Pain Management Steering Committee which have worked to improve substance use disorder treatment at NYU Langone.
|
|
|
|
|
|
|
|
|
|
|
|
Speakers
Presentations:
| ID | Duration | # | Presentation Title | Presentation Type | Details |
